To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@nih.gov along with the following information:

  • Your name, title, and organization
  • Study Number and Study Title
  • The specific dataset(s) you are requesting
  • The intended use or purpose of the data
  • Willingness to comply with the NIDA Datashare Registration Agreement
Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-CTN-0009

Division
HEAL Study
Investigator(s)
Title
Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs
Short Description
To study the feasibility of incorporating a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and to see if adding such a program will help people quit smoking and stay off of drugs and alcohol better than substance abuse treatment alone.
Release Date
Dec 03, 2007
Description

The prevalence of cigarette smoking among substance abusers is high, and substance abusers who smoke have more health problems, higher death rates, and more severe drug and alcohol addiction than those who don't. In the past decade, studies have demonstrated that smoking cessation programs and smoke-free policies can be successful in drug and alcohol rehabilitation clinics. Patients stay in treatment longer, they stop smoking for a time, and they do not use more drugs or alcohol than other patients. This study looks at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and to see if adding such a program will help people quit smoking and stay off of drugs and alcohol better than substance abuse treatment alone. The treatment for quitting smoking consists of group counseling in combination with the nicotine skin patch (NicoDerm CQ).

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Links